Return to News Categories

Commentary and Educational Cattle - Hogs / Livestock News Currencies News Energy News Grain News Index News Interest Futures News Metals Futures News Reports: Crops, CFTC, etc Soft Commodities News

Futures and Commodity Market News

Global Gene Therapy Market Analysis & Forecast to 2022 -

The "Global Gene Therapy Market Analysis & Forecast to 2022" report has been added to's offering.

The global gene therapy market is forecast to hit $363 million by 2022.

Strengthened by recent approvals of Kymriah, Yescarta and Luxturna in the US, and a committed European, Japanese and Chinese environment, gene therapy is set to become a significant player in the bio-pharmaceutical industry. The space covers many therapeutic areas specifically, oncology, rare diseases, Parkinson's, HIV, severe combined immuno-deficiencies (SCID) and hemophilia.

Gene therapy is driven by over 2,200 clinical trials globally, with over 55% of this occurring in the US, followed by Europe, Canada and China. Recently, in November 2017, the FDA indicated that gene therapies will now qualify for a fast approval process, which will bring more therapies to market faster. However, the space also has significant challenges, such as manufacturing logistics, reimbursement and its high cost.

Key Topics Covered:

1.0 Introduction

2.0 Gene Therapy: The Basics

3.0 Historic Overview of Gene Therapy

4.0 Gene Therapy Phase III Product Candidates

5.0 Gene Therapy Phase II Product Candidates

6.0 Commercialization, Cost and Warranty of Gene Therapies

7.0 The Strength of Gene Therapy Industry

8.0 Vectors for Gene Delivery

9.0 Clinical Applications of Gene Therapy

10.0 Market Analysis

11.0 Manufacturing of Viral Vectors and Logistics

12.0 Company Profiles

AGCT Abeona Therapeutics LLC Amgen AnGes MG Inc. BioCancell Therapeutic Inc. BioMarin Pharmaceutical Inc. Copernicus Therapeutics Inc. Dimension Therapeutics Inc. Editas Medicine Inc. Fibrocell Sciences Inc. Florida Biologix Fondazione Telethon Genzyme (Sanofi) GlaxoSmithKline Glybera Medgenics Inc. Mirus Bio LLC Molecular Therapeutics LLC Mologen AG NightstaRx Ltd. Novartis Novasep Process SAS ORCA Therapeutics B.V. Omnia Biologics Inc. Sanofi Sarepta Therapeutics Inc. Shanghai Sunway Biotech Co. Ltd. SiBiono GeneTech Co. Ltd. Sirion Biotech GmbH Spark Therapeutics Inc. Takara Bio Inc. Taxus Cardium Pharmaceutical Group Inc. Vical Inc. Voyager Therapeutics Xenon Pharmaceuticals Inc.

For more information about this report visit

View source version on

SOURCE: Research and Markets 
Laura Wood, Senior Manager 
For E.S.T Office Hours Call 1-917-300-0470 
For U.S./CAN Toll Free Call 1-800-526-8630 
For GMT Office Hours Call +353-1-416-8900 
Related Topics: Genomics

Copyright Business Wire 2018

Please read the End User Agreement.
By accessing this page, you agree to the terms and conditions of the End User Agreement.

News provided by COMTEX.

Lt Crude 64.55
Nat Gas 2.673
Corn 374 6/8
Cotton #2 83.61
Gold 1320.6
Copper 3.0435
Euro 1.23680
USD Index 89.660
SP500 E-mini 2717.00
DJIA E-mini 24667